Expand AXGN Menu
AXGN MENU

AXGN Latest Press Releases

-- December 17, 2025 --

Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference Globe Newswire 7:00 AM

-- December 3, 2025 --

Axogen Announces FDA Approval of Biologics License Application for AVANCE (acellular nerve allograft-arwx) Globe Newswire 8:01 PM

-- November 4, 2025 --

Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences Globe Newswire 7:00 AM

-- October 29, 2025 --

Axogen, Inc. Reports Third Quarter 2025 Financial Results Globe Newswire 7:00 AM

-- October 18, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN PRNewswire 10:00 AM

-- October 15, 2025 --

Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025 Globe Newswire 7:00 AM

-- October 13, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN PRNewswire 1:42 PM

-- October 8, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN PRNewswire 5:44 PM

-- October 3, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN PRNewswire 10:00 AM

-- October 1, 2025 --

Axogen, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - AXGN Business Wire 12:30 PM
AXGN Investors Have Opportunity to Join Axogen, Inc. Fraud Investigation with the Schall Law Firm Business Wire 10:50 AM

-- September 28, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN PRNewswire 10:00 AM

-- September 24, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN Globe Newswire 4:39 PM

-- September 23, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN PRNewswire 10:00 AM

-- September 18, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN PRNewswire 10:00 AM

-- September 13, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN PRNewswire 1:30 PM

-- September 10, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN Globe Newswire 2:21 PM

-- September 8, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN PRNewswire 3:00 PM

-- September 6, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN Globe Newswire 10:00 AM

-- August 27, 2025 --

Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences Globe Newswire 8:00 AM

-- August 25, 2025 --

Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft Globe Newswire 6:40 AM
Market Data Delayed 15 Minutes